The global breast reconstruction market size is expected to grow from USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0%. This industry is experiencing significant growth due to rising incidences of breast cancer, increasing awareness, and the availability of reimbursements.
The breast implants segment is expected to dominate the breast reconstruction market
Based on the product, the breast reconstruction market industry is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2019. This is primarily attributed to the increasing incidences of breast cancer and the rising number of breast reconstruction procedures.
Silicone implants hold the largest share of the market for breast implants
The breast implants market is segmented into silicone and saline implants. Silicone implants accounted for the largest market share in 2019 due to the large number of silicone breast implantation procedures performed across the globe.
North America was the largest regional market for breast reconstruction in 2019
The breast reconstruction market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America held the largest share of the market, followed by Europe. The rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products in this region are the major factors driving the growth of the breast reconstruction in North America.
Key Market Players
The prominent players operating in this market include Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (Costa Rica), Silimed (Brazil), Laboratories Arion (France), Guangzhou Wanhe Plastic Materials Co. Ltd.(China), CEREPLAS (France), HansBiomed (South Korea), PMT Corporation (US), and Shanghai Kangning Medical Device (China)
Johnson & Johnson is one of the leading players in the breast reconstruction market. The company offers a broad product portfolio across the globe. Over the years, the company has maintained its leading position in the breast reconstruction market.